Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal International Journal of Nasopharyngeal Carcinoma
Feri Danil
Otorhinolaryngology Department, Gatot Soebroto Central Army Hospital, Jakarta, Indonesia
Health Professions Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
RESPONSE OUTCOMES OF CONCURRENT CHEMORADIOTHERAPY (CCRT) FOR STAGE III NASOPHARYNGEAL CARCINOMA Feri Danil
INTERNATIONAL JOURNAL OF NASOPHARYNGEAL CARCINOMA Vol. 2 No. 01 (2020): International Journal of Nasopharyngeal Carcinoma
Publisher : TALENTA PUBLISHER

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32734/ijnpc.v2i01.3596

Abstract

Introduction: Nasopharyngeal carcinoma (NPC) is a rare malignancy with an incidence of 0.5-2 per 100,000 in Europe and the United States [1]. NPC has high prevalence in certain regions of the world, especially in Southeast Asia with a poor prognosis. In Indonesia, the prevalence of NPC is 6.2/100 000, with 13 000 yearly new cases, [2]. NPC is the forth most cancer found in Indonesia. Case Report: This paper reported a case of 39 years old man with nasopharyngeal carcinoma and subsequently underwent concurrent chemoradiotherapy (CCRT). Conclusion: The purpose of this paper is to explain experience at one of the largest single-centre of weekly cisplatin concurrently with radiotherapy with potential to be an optimal therapeutic regiment in the nonsurgical management of squamous cell carcinoma of head and neck (SCCHN) clinical stage III.
Co-Authors